Influence of Perception of Patients Suffering of Knee Osteoarthritis Regarding Effectiveness of Intra-articular Injection
NCT ID: NCT02835521
Last Updated: 2016-07-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
100 participants
INTERVENTIONAL
2016-08-31
2017-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Objective: to evaluate the influence of perception of patients suffering of knee osteoarthritis over fear, catastrophizing of pain and effectiveness, related to intra-articular injection od corticosteroids.
Material and method: it will be performed a prospective, controlled and randomized study eith a blind evaluator on patients with symptomatic knee osteoarthritis submitted to joint injection. A hundred patients suffering of symptomatic knee osteoarthritis coming from the outpatient area of Rheumatology Division of Federal University of Sao Paulo (UNIFESP) will be evaluated, 50 belonging to the intervention group (reception) and 50 to a control group.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Educational Program for Knee Osteoarthritis
NCT03588195
Ultrasound-guided Genicular Nerve Block With Phenol for the Treatment of Chronic Pain Due to Knee Osteoarthritis
NCT03601533
Effects of Semi-standarized Acupuncture in Chronical Symptomatic Osteoarthritis of the Knee Through: A Randomized Controlled Trial
NCT05096806
The Effect of Cryotherapy in Pain Control, Function and Quality of Life in Individuals With Knee Osteoarthritis
NCT02725047
Influence of Central Sensitization on Efficacy of Patient-controlled Epidural Analgesia in Osteoarthritis Patients Undergoing Total Knee Replacement
NCT01863342
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention Group
Patients will receive the reception treatment before the joint injection
Reception
Joint injection with triamcinolone hexacetonide
joint injection with corticosteroids
Control Group
patient will receive a joint injection
Joint injection with triamcinolone hexacetonide
joint injection with corticosteroids
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Reception
Joint injection with triamcinolone hexacetonide
joint injection with corticosteroids
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* no previous experience of joint injection
* stable use of drugs for osteoarthritis treatment for at least 3 months
* stable dose of corticosteroids, non hormonal anti-inflammatory and analgesics in the previous month
* pain on knee between 3 and 7 in the visual analogue scale
* signe the informed consent term
* radiologic classification between 1-3 (kellgren and Lawrence classification)
Exclusion Criteria
* coagulation alteration
* non treated fibromyalgia
* litigation
* diabetes mellitus and systemic arterial hypertension out of control
* allergy of lidocaine or triamcinolone hexacetonide
50 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Federal University of São Paulo
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sandra Regina Toffolo
Principal Investigator
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CEP UNIFESP - 849746
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.